"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."

During the past decade, Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001)" are "Pneumococcal Infections" (2 trials), "Lower Respiratory Tract Disease" (1 trials), "Respiratory Syncytial Virus" (1 trials) and "Respiratory Syncytial Viruses" (1 trials). Many other conditions were trialed in "Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001)" in a lesser frequency.

Most popular intervention types in "Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001)" are "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad26.RSV.preF" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "Nimenrix" (1 trials) and "Prevnar 13®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".